Search research articles
Contact Us
Filters
Showing results (221-230 of 263) with videos related to
Page
of 27
Sort By:
Cancer Research
|
April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors
T M Behr, R M Sharkey, M I Juweid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1995
Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer
T M Behr, W S Becker, H J Bair, et al.
International Journal of Cancer
|
August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
T M Behr, S Memtsoudis, R M Sharkey, et al.
Genes and Immunity
|
May 9, 2014
Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections
S M Dauphinee, E Richer, M M Eva, et al.
European Journal of Immunology
|
March 19, 2024
Intestinal tissue-resident memory T cells maintain distinct identity from circulating memory T cells after in vitro restimulation
Ammarina Beumer-Chuwonpad, Felix M Behr, Floris P J van Alphen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
T M Behr, B Wörmann, M Gramatzki, et al.
Cancer
|
March 6, 2002
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer
Thomas M Behr, Torsten Liersch, Lutz Greiner-Bechert, et al.
Science Immunology
|
December 16, 2018
<b>T</b> <sub></sub> <b>maintenance is regulated by tissue damage via P2RX7</b>
Regina Stark, Thomas H Wesselink, Felix M Behr, et al.
Cancer
|
December 24, 1997
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry
T M Behr, R M Sharkey, G Sgouros, et al.
Cancer Research
|
June 11, 1999
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model
T M Behr, M Béhé, M G Stabin, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 263) with videos related to
Sort By:
Page
of 27
Cancer Research
|
April 15, 1996
Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors
T M Behr, R M Sharkey, M I Juweid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1995
Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer
T M Behr, W S Becker, H J Bair, et al.
International Journal of Cancer
|
August 4, 1998
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy
T M Behr, S Memtsoudis, R M Sharkey, et al.
Genes and Immunity
|
May 9, 2014
Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections
S M Dauphinee, E Richer, M M Eva, et al.
European Journal of Immunology
|
March 19, 2024
Intestinal tissue-resident memory T cells maintain distinct identity from circulating memory T cells after in vitro restimulation
Ammarina Beumer-Chuwonpad, Felix M Behr, Floris P J van Alphen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 1999
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
T M Behr, B Wörmann, M Gramatzki, et al.
Cancer
|
March 6, 2002
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer
Thomas M Behr, Torsten Liersch, Lutz Greiner-Bechert, et al.
Science Immunology
|
December 16, 2018
<b>T</b> <sub></sub> <b>maintenance is regulated by tissue damage via P2RX7</b>
Regina Stark, Thomas H Wesselink, Felix M Behr, et al.
Cancer
|
December 24, 1997
Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry
T M Behr, R M Sharkey, G Sgouros, et al.
Cancer Research
|
June 11, 1999
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model
T M Behr, M Béhé, M G Stabin, et al.
Page
of 27